The Detection of 5-Hydroxymethylcytosine in Neural Stem Cells and Brains of Mice
September 19th, 2019
Here, we present a protocol to detect 5-hydroxymethylcytosine in cells and brain tissues, utilizing immunofluorescence staining and DNA dot-blot methods.
Here, we present a protocol to detect 5-hydroxymethylcytosin in cells and the brain tissues using immunofluorescence, the new method, and the DNA dot-blot. 5-hydroxymethylcytosin, i.e. 5hmC, mitigated epigenetic modification, plays important function in regulating gene expression and involved in multiple neurological disorders.
Actually, our methods can be used to detect 5hmC in multiple cells and the tissues. It's convenient and can be performed with common equipments in the lab. Begin by positioning the mouse face up on a plastic board and fixing each limb with sticky tape.
Use surgical scissors to cut through the skin and muscle, and open the thoracic cavity. Expose the heart and cut off a small part of the right atrium with fine surgical scissors. Using a 10-milliliter disposable, sterilized syringe, perfuse the mouse from the left ventricle with cold PBS.
Then, perfuse the mouse with 4%PFA until it is stiff. Then, open the skull with bone forceps and remove the brain. Place the brain into a 15-milliliter centrifuge tube filled with five milliliters of 4%PFA and store it at four degrees Celsius.
After 24 hours, transfer the brain into a 30%sucrose solution and leave it at four degrees Celsius for complete dehydration. Prior to sectioning, imbed the brain in optimal cutting temperature compound and cool to minus 20 degrees Celsius for at least one hour. Section brain samples at a thickness of 20 to 40 micrometers using a cryostat microtome.
Collect sections into PBS and store at four degrees Celsius. Pick up the brain sections of interest and put them into a 24-well plate with PBS. Wash sections with PBS on a shaker for 10 minutes.
Remove the PBS and treat with preheated one-molar hydrochloric acid at 37 degrees Celsius for 30 minutes. Hydrochloric acid is corrosive and please prepare it in the chemical hold. Then, wash the samples three times with PBS for five minutes and block them with PBS containing 3%normal goat serum and 0.1%Triton X-100.
Leave the samples on a shaker at room temperature for one hour. Add specific primary antibodies to the sections and incubate overnight at four degrees Celsius on a shaker. The next day, take the samples out and leave them at room temperature for one hour.
Wash the samples three times with PBS and add secondary antibodies. Cover the plate with aluminum and leave it at room temperature for one hour while shaking. After the incubation, wash the samples three times with PBS and mount them onto slides.
Add 100 to 150 microliters of anti-fade mounting medium, cover with a premium cover glass, and seal with nail polish. Image the brain sections with a regular or confocal microscope. To isolate genomic DNA, start by dissecting the hippocampus, cortex, and cerebellum tissues on an ice-cooled dish.
Add one milliliter of DNA lysis buffer and grind the tissues. Transfer the sample into a clean microcentrifuge tube and add 250 micrograms of proteinase-K for every 600 microliters of lysis buffer. Then, add about 50 micrograms of RNase A per sample and incubate for at least 12 hours at 37 degrees Celsius.
After the incubation, add an equal volume of phenol chloroform isoamyl alcohol and mix thoroughly. Centrifuge the mixture according to manuscript directions and transfer the supernatant to a new tube. Add 600 microliters of chloroform to the supernatant, mix thoroughly, and centrifuge according to manuscript directions.
Transfer the supernatant to a new tube and add 500 microliters of isopropanol. Mix thoroughly and centrifuge again to precipitate the DNA. After the centrifugation, discard the supernatant, and wash the DNA pellet with 70%ethanol according to manuscript directions.
Air dry the DNA pellet completely and then, dissolve it in Tris-HCl buffer. Prior to starting, prepare the required solutions and sample mixture according to manuscript directions. Denature the DNA sample by heating it to 100 degrees Celsius for 10 minutes and then, place it on ice.
Cut the appropriate size of a nylon membrane and rinse it with 6X SSC. Place the membrane on a dot-blot apparatus and connect the vacuum pump. Spot six-microliter dots onto the membrane and hybridize for 30 minutes at 80 degrees Celsius.
Then, block the sample membrane with fat-free milk and Tris-buffered saline, or TBS, for one hour. Add the polyclonal rabbit anti-5-hydroxymethylcytosin antibody to the membrane and incubate overnight at four degrees Celsius. The next day, leave the sample membrane at room temperature for one hour, then wash the membrane three times with TBS.
Incubate the membrane with the anti-rabbit secondary antibody for 30 minutes and then, wash three times with TBS. Visualize the chemiluminescence signals and quantify their intensity. This protocol can be used to visualize 5-hydroxymethylcytosin, or 5hmC, in the hippocampus of adult mice.
Immunofluorescence with antibodies against neuronal cells, the 5hmC reveals that there is an enrichment of 5hmC in neurons. Dynamics of 5hmC during neuronal development can be determined with a dot-blot assay of DNA samples isolated from proliferating and differentiated adult neural stem cells. Global levels of 5hmC significantly increase during differentiation and the level of 5hmC in neurons is higher than in neural stem cells.
The key step of this method is to make sure that complete denaturation of DNA samples.
View the full transcript and gain access to thousands of scientific videos
Overview
This study presents a protocol for detecting 5-hydroxymethylcytosine (5hmC) in cells and brain tissues through immunofluorescence staining and DNA dot-blot methods. The findings aim to elucidate the role of 5hmC in gene regulation and its implications in neurological disorders, leveraging techniques suitable for laboratory settings.
Key Study Components
Area of Science
- Epigenetics
- Neuroscience
- Cell Biology
Background
- 5-hydroxymethylcytosine (5hmC) is a key epigenetic modification.
- It plays a fundamental role in regulating gene expression.
- 5hmC has been linked to various neurological disorders.
- The study proposes methods for convenient detection of 5hmC in multiple types of cells and tissues.
Purpose of Study
- To detect 5hmC in neural tissue to understand its function in gene regulation.
- To provide a reliable protocol using basic lab equipment.
- To investigate the dynamics of 5hmC during neuronal development.
Methods Used
- The protocol incorporates immunofluorescence staining and a DNA dot-blot assay.
- Mouse brain tissues are utilized for detecting 5hmC levels.
- Key steps include tissue preparation, DNA isolation, and antibody labeling.
- Critical steps involve fixation, dehydration, sectioning of tissue, and hybridization processes.
- Microscopy is employed for imaging the stained sections.
Main Results
- The study demonstrates significant enrichment of 5hmC in neurons compared to neural stem cells.
- Global levels of 5hmC increase during neuronal differentiation.
- Successful visualization of 5hmC highlights its potential as a biomarker for studying neural development.
- Mechanistic insights into 5hmC dynamics are provided through the experimental findings.
Conclusions
- This protocol enables reliable detection of 5hmC, facilitating further research into its role in neuronal function and disease.
- Understanding 5hmC dynamics can aid in uncovering mechanisms underlying neurological conditions.
- These methodologies offer a foundation for future investigations in epigenetic regulation in neuroscience.
Frequently Asked Questions
Executive Industry Relevance
Detection of 5-hydroxymethylcytosine (5hmC) supports epigenetic target validation in neuroscience drug discovery by enabling quantitative assessment of DNA modification dynamics in neural stem cells and brain tissues. This method provides mechanistic de-risking for therapeutic hypotheses involving gene regulation pathways linked to neurological disorders. Reliable 5hmC measurement enhances predictive confidence in preclinical models by connecting epigenetic biomarkers to functional outcomes in neuronal differentiation and disease models.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of epigenetic mechanisms regulating gene expression in neuronal development and disease contexts.
- Operational Value: Provides a standardized approach to assess 5hmC enrichment in neurons versus neural stem cells for target hypothesis testing.
- Predictive Value: Supports biomarker qualification by correlating 5hmC levels with differentiation states and neurological disorder models.
Screening & Assay Development
- Assay Readiness: Generates quantitative dot-blot signals that can be normalized and compared across experimental conditions for screening applications.
- Reproducibility: Uses standardized fixation, sectioning, and antibody incubation steps to ensure consistent 5hmC detection across tissue samples.
- Scalability: Compatible with common laboratory equipment enabling adaptation to multi-well formats for higher throughput epigenetic profiling.
Translational & Preclinical Research
- Disease Relevance: Detects 5hmC dynamics in hippocampus, cortex, and cerebellum tissues, supporting translational studies in neurological disorder models.
- Translational Continuity: Links in vitro neural stem cell differentiation to in vivo brain tissue analysis for cross-system validation of epigenetic targets.
- Risk-Adjusted Decisions: Enables monitoring of 5hmC changes during preclinical development to inform go/no-go criteria based on epigenetic modulation.
Pipeline & Workflow Integration
The method fits within the discovery continuum from target validation through preclinical development by providing epigenetic readouts that inform mechanism-based compound screening and biomarker strategy.
- Discovery Biology: Supports hypothesis testing of epigenetic regulators by measuring 5hmC changes in response to genetic or pharmacological perturbations.
- Screening: Enables epigenetic profiling of compound libraries using dot-blot quantification to identify modulators of 5hmC levels in neural systems.
- Analytics: Generates quantitative chemiluminescence intensity data from dot-blot assays that allow statistical comparison of 5hmC across conditions and timepoints.
- Translational Research: Connects cellular epigenetic states to tissue-level modifications in mouse brain models, supporting biomarker translation.
- Enterprise Reuse: Establishes a standardized epigenetic detection platform applicable across multiple neuroscience projects and target validation efforts.
Operational & Enterprise Impact
- Scientific Value: Provides mechanistic insight into epigenetic regulation of gene expression in neuronal development and disease models.
- Operational Value: Uses accessible laboratory techniques (immunofluorescence, dot-blot) requiring standard equipment and reagents.
- Strategic Value: Informs target selection and compound prioritization by linking epigenetic modulation to phenotypic outcomes in neural systems.
- Portfolio Impact: Enables risk-adjusted advancement of epigenetic therapeutics by providing quantifiable biomarker data for decision-making.
Implementation Considerations
- Requires expertise in histology, immunohistochemistry, and nucleic acid handling for tissue sectioning and DNA isolation procedures.
- Dependent on specific antibody validation and optimization for sensitive and specific 5hmC detection in immunofluorescence and dot-blot formats.
- Necessitates standardized tissue processing protocols including fixation, dehydration, and sectioning to ensure reproducible results across experiments.
- Involves hazardous reagents (hydrochloric acid, phenol-chloroform) requiring appropriate safety protocols and chemical handling expertise.
- Limited by the need for precise DNA denaturation as a critical step affecting dot-blot signal accuracy and requiring careful optimization.
